CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Orthofix - OFIX CFD

    10.75
    2.36%
    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.06
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.026207 %
    Charges from full value of position ($-4.98)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.026207%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee 0.003985 %
    Charges from full value of position ($0.76)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		0.003985%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency USD
    Margin 5%
    Stock exchange United States of America
    Commission on trade 0%

    *Information provided by Capital.com

    Orthofix Medical Inc ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 11.01
    Open* 10.73
    1-Year Change* -40.16%
    Day's Range* 10.65 - 10.81
    52 wk Range 9.58-23.19
    Average Volume (10 days) 883.41K
    Average Volume (3 months) 15.63M
    Market Cap 411.31M
    P/E Ratio -100.00K
    Shares Outstanding 36.76M
    Revenue 598.45M
    EPS -3.66
    Dividend (Yield %) N/A
    Beta 1.03
    Next Earnings Date Mar 4, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Nov 30, 2023 11.01 -0.17 -1.52% 11.18 11.37 10.99
    Nov 29, 2023 11.23 0.01 0.09% 11.22 11.57 11.21
    Nov 28, 2023 11.20 -0.29 -2.52% 11.49 11.92 11.13
    Nov 27, 2023 11.62 0.57 5.16% 11.05 11.67 11.05
    Nov 24, 2023 11.43 0.33 2.97% 11.10 11.50 11.09
    Nov 22, 2023 11.30 0.05 0.44% 11.25 11.59 11.13
    Nov 21, 2023 11.17 0.93 9.08% 10.24 11.20 10.24
    Nov 20, 2023 10.78 0.61 6.00% 10.17 10.86 10.16
    Nov 17, 2023 10.47 0.06 0.58% 10.41 10.62 10.33
    Nov 16, 2023 10.36 -0.02 -0.19% 10.38 10.66 10.15
    Nov 15, 2023 10.70 0.31 2.98% 10.39 10.74 10.37
    Nov 14, 2023 10.43 0.58 5.89% 9.85 10.48 9.85
    Nov 13, 2023 9.65 -0.33 -3.31% 9.98 10.06 9.54
    Nov 10, 2023 9.99 -0.63 -5.93% 10.62 10.63 9.67
    Nov 9, 2023 10.58 -0.31 -2.85% 10.89 11.33 10.52
    Nov 8, 2023 11.81 -0.17 -1.42% 11.98 12.11 11.61
    Nov 7, 2023 12.11 -0.20 -1.62% 12.31 12.44 12.07
    Nov 6, 2023 12.30 0.17 1.40% 12.13 12.46 12.01
    Nov 3, 2023 12.24 0.27 2.26% 11.97 12.42 11.97
    Nov 2, 2023 11.66 0.62 5.62% 11.04 11.81 10.98

    Orthofix Events

    Time (UTC) Country Event
    Monday, March 4, 2024

    Time (UTC)

    10:59

    Country

    US

    Event

    Q4 2023 Orthofix Medical Inc Earnings Release
    Q4 2023 Orthofix Medical Inc Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 460.713 464.479 406.562 459.955 453.042
    Revenue 460.713 464.479 406.562 459.955 453.042
    Cost of Revenue, Total 123.544 114.914 101.889 100.607 96.628
    Gross Profit 337.169 349.565 304.673 359.348 356.414
    Total Operating Expense 473.981 472.794 412.828 478.739 422.948
    Selling/General/Admin. Expenses, Total 308.776 290.671 272.382 309.283 290.033
    Research & Development 49.065 49.621 39.056 34.637 33.218
    Unusual Expense (Income) 1.6 13.256 34.212 0
    Other Operating Expenses, Total -17.2 -3.575 -7.3 3.069
    Operating Income -13.268 -8.315 -6.266 -18.784 30.094
    Interest Income (Expense), Net Non-Operating -1.288 -1.837 -2.483 -0.122 -0.828
    Other, Net -3.15 -3.343 8.381 -8.143 -6.381
    Net Income Before Taxes -17.706 -13.495 -0.368 -27.049 22.885
    Net Income After Taxes -19.749 -38.379 2.517 -28.462 13.251
    Net Income Before Extra. Items -19.749 -38.379 2.517 -28.462 13.251
    Total Extraordinary Items 0 0.56
    Net Income -19.749 -38.379 2.517 -28.462 13.811
    Income Available to Common Excl. Extra. Items -19.749 -38.379 2.517 -28.462 13.251
    Income Available to Common Incl. Extra. Items -19.749 -38.379 2.517 -28.462 13.811
    Diluted Net Income -19.749 -38.379 2.517 -28.462 13.811
    Diluted Weighted Average Shares 20.0536 19.6906 19.3917 18.9033 18.9116
    Diluted EPS Excluding Extraordinary Items -0.98481 -1.9491 0.1298 -1.50566 0.70068
    Diluted Normalized EPS -0.90503 -1.48485 0.1298 -0.32927 0.70068
    Depreciation / Amortization 8.196 7.907 6.801
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 187.016 175.204 122.229 113.996 118.07
    Revenue 187.016 175.204 122.229 113.996 118.07
    Cost of Revenue, Total 67.465 64.875 33.053 30.573 31.6
    Gross Profit 119.551 110.329 89.176 83.423 86.47
    Total Operating Expense 223.648 234.918 133.273 119.783 111.429
    Selling/General/Admin. Expenses, Total 133.426 142.602 84.794 74.783 75.734
    Research & Development 19.424 23.307 13.152 11.943 12.758
    Depreciation / Amortization 4.633 4.134 2.074 2.07 2.051
    Unusual Expense (Income) 0.2 1.4
    Other Operating Expenses, Total -1.3 0 0 -0.986 -10.714
    Operating Income -36.632 -59.714 -11.044 -5.787 6.641
    Interest Income (Expense), Net Non-Operating -1.266 -1.289 -0.229 -0.277 -0.407
    Other, Net -0.02 0.676 4.286 -3.308 -3.192
    Net Income Before Taxes -37.918 -60.327 -6.987 -9.372 3.042
    Net Income After Taxes -39.426 -60.938 -7.062 -10.716 2.489
    Net Income Before Extra. Items -39.426 -60.938 -7.062 -10.716 2.489
    Net Income -39.426 -60.938 -7.062 -10.716 2.489
    Income Available to Common Excl. Extra. Items -39.426 -60.938 -7.062 -10.716 2.489
    Income Available to Common Incl. Extra. Items -39.426 -60.938 -7.062 -10.716 2.489
    Diluted Net Income -39.426 -60.938 -7.062 -10.716 2.489
    Diluted Weighted Average Shares 36.762 35.734 20.1932 20.091 20.113
    Diluted EPS Excluding Extraordinary Items -1.07247 -1.70532 -0.34972 -0.53337 0.12375
    Dividends per Share - Common Stock Primary Issue 0 0 0 0
    Diluted Normalized EPS -1.07247 -1.70532 -0.33982 -0.46369 0.12375
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 255.99 269.522 270.379 260.553 244.639
    Cash and Short Term Investments 50.7 87.847 96.291 69.719 69.623
    Cash & Equivalents 50.7 87.847 96.291 69.719 69.623
    Total Receivables, Net 82.857 78.56 72.423 86.805 77.747
    Accounts Receivable - Trade, Net 82.857 78.56 72.423 86.805 77.747
    Total Inventory 100.15 82.974 84.635 82.397 76.847
    Prepaid Expenses 22.283 20.141 16.5 20.948 17.856
    Other Current Assets, Total 0.53 0.684 2.566
    Total Assets 458.629 476.623 525.861 495.62 466.641
    Property/Plant/Equipment, Total - Net 65.017 62.407 68.453 64.602 42.835
    Property/Plant/Equipment, Total - Gross 228.013 245.371 237.901 214.807 181.862
    Accumulated Depreciation, Total -162.996 -182.964 -169.448 -150.205 -139.027
    Goodwill, Net 71.317 71.317 84.018 71.177 72.401
    Intangibles, Net 47.388 52.666 60.517 54.139 51.897
    Other Long Term Assets, Total 17.817 19.311 40.494 44.149 52.969
    Total Current Liabilities 83.624 105.83 103.899 84.883 85.908
    Accounts Payable 27.598 26.459 23.118 19.886 17.989
    Accrued Expenses 44.154 47.118 45.297 42.967 42.083
    Notes Payable/Short Term Debt 0 0 0 0 0
    Other Current Liabilities, Total 11.22 29.663 34.974 21.707 25.836
    Total Liabilities 121.769 139.689 168.997 167.989 131.244
    Total Long Term Debt 19.239 19.89 22.338 20.648 0
    Other Liabilities, Total 18.906 13.969 42.76 62.458 45.336
    Total Equity 336.86 336.934 356.864 327.631 335.397
    Common Stock 2.016 1.983 1.942 1.902 1.858
    Additional Paid-In Capital 334.969 313.951 292.291 271.019 243.165
    Retained Earnings (Accumulated Deficit) 1.251 21 59.379 57.749 87.078
    Other Equity, Total -1.477 0 3.252 -3.039 3.296
    Total Liabilities & Shareholders’ Equity 458.629 476.623 525.861 495.62 466.641
    Total Common Shares Outstanding 20.162 19.8369 19.4239 19.0226 18.5797
    Note Receivable - Long Term 1.1 1.4 2 1 1.9
    Current Port. of LT Debt/Capital Leases 0.652 2.59 0.51 0.323
    Capital Lease Obligations 19.239 19.89 22.338 20.648
    Unrealized Gain (Loss) 0.101
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 393.696 399.348 410.041 255.99 246.895
    Cash and Short Term Investments 33.663 37.607 49.968 50.7 51.66
    Cash & Equivalents 33.663 37.607 49.968 50.7 51.66
    Total Receivables, Net 114.118 112.32 113.313 82.857 75.633
    Accounts Receivable - Trade, Net 114.118 112.32 113.313 82.857 75.633
    Total Inventory 221.745 222.474 221.933 100.15 100.277
    Prepaid Expenses 24.17 26.947 24.827 22.283 19.325
    Other Current Assets, Total
    Total Assets 905.652 901.287 917.136 458.629 449.66
    Property/Plant/Equipment, Total - Net 172.454 161.018 158.098 65.017 64.639
    Goodwill, Net 194.767 191.727 202.711 71.317 71.317
    Intangibles, Net 121.021 126 122.129 47.388 47.513
    Note Receivable - Long Term 1.1 1.3
    Other Long Term Assets, Total 23.714 23.194 24.157 17.817 17.996
    Total Current Liabilities 152.53 141.804 137.568 83.624 77.648
    Accounts Payable 53.261 51.349 45.875 27.598 28.003
    Accrued Expenses 3.259 3.159 3.241 1.638 1.503
    Notes Payable/Short Term Debt 0 0 0 0 0
    Current Port. of LT Debt/Capital Leases 0.693 0.678 0.664 0.652 0.638
    Other Current Liabilities, Total 95.317 86.618 87.788 53.736 47.504
    Total Liabilities 290.169 261.302 252.977 121.769 116.121
    Total Long Term Debt 88.715 69.894 64.068 19.239 19.407
    Capital Lease Obligations 18.715 18.894 19.068 19.239 19.407
    Other Liabilities, Total 48.924 49.604 51.341 18.906 19.066
    Total Equity 615.483 639.985 664.159 336.86 333.539
    Common Stock 3.675 3.673 3.647 2.016 2.001
    Additional Paid-In Capital 741.638 735.533 721.145 334.969 328.387
    Retained Earnings (Accumulated Deficit) -127.97 -99.113 -59.687 1.251 8.313
    Other Equity, Total -1.86 -0.41 -1.121 -1.477 -5.179
    Total Liabilities & Shareholders’ Equity 905.652 901.287 917.136 458.629 449.66
    Total Common Shares Outstanding 36.75 36.733 36.463 20.162 20.007
    Unrealized Gain (Loss) 0 0.302 0.175 0.101 0.017
    Long Term Debt 70 51 45
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line -19.749 -38.379 2.517 -28.462 13.811
    Cash From Operating Activities -11.538 18.475 74.272 32.033 49.918
    Cash From Operating Activities 29.019 29.599 30.546 24.699 18.659
    Deferred Taxes 0.314 24.482 10.787 1.393 -2.661
    Non-Cash Items 8.113 27.471 10.724 62.442 27.107
    Cash Taxes Paid
    Cash Interest Paid
    Changes in Working Capital -29.235 -24.698 19.698 -28.039 -6.998
    Cash From Investing Activities -24.534 -23.013 -52.334 -22.924 -60.998
    Capital Expenditures -24.534 -20.842 -24.334 -22.924 -16.704
    Other Investing Cash Flow Items, Total 0 -2.171 -28 -44.294
    Cash From Financing Activities -0.078 -3.621 3.245 -10.688 2.993
    Financing Cash Flow Items -1.821 -11.908 -4.03 -21.874 -4.107
    Issuance (Retirement) of Stock, Net 4.337 8.824 7.598 11.551 7.1
    Issuance (Retirement) of Debt, Net -2.594 -0.537 -0.323 -0.365
    Foreign Exchange Effects -0.997 -0.815 1.235 -0.207 -0.881
    Net Change in Cash -37.147 -8.974 26.418 -1.786 -8.968
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line -60.938 -19.749 -12.687 -1.971 -4.46
    Cash From Operating Activities -34.02 -11.538 -13.886 -12.622 -7.709
    Cash From Operating Activities 12.67 29.019 21.598 14.028 7.516
    Deferred Taxes 0.379 0.314 0.021 0.236 -0.036
    Non-Cash Items 33.382 8.113 1.733 -3.379 0.749
    Changes in Working Capital -19.513 -29.235 -24.551 -21.536 -11.478
    Cash From Investing Activities 17.084 -24.534 -18.634 -13.161 -5.667
    Capital Expenditures -11.835 -24.534 -17.26 -11.703 -5.667
    Cash From Financing Activities 15.983 -0.078 -1.576 -1.324 -2.233
    Financing Cash Flow Items -1.958 -1.821 -1.535 -1.433 -0.092
    Issuance (Retirement) of Stock, Net 4.337 2.4 2.4 0
    Issuance (Retirement) of Debt, Net 17.941 -2.594 -2.441 -2.291 -2.141
    Foreign Exchange Effects 0.221 -0.997 -2.091 -1.204 -0.321
    Net Change in Cash -0.732 -37.147 -36.187 -28.311 -15.93
    Other Investing Cash Flow Items, Total 28.919 0 -1.374 -1.458
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 15.0824 5541074 -887 2023-06-30 LOW
    First Light Asset Management, LLC Investment Advisor/Hedge Fund 6.6936 2459129 -191842 2023-06-30 LOW
    Armistice Capital LLC Hedge Fund 6.6306 2436000 600000 2023-06-30 MED
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 6.5243 2396937 -23954 2023-06-30 LOW
    Rubric Capital Management LP Hedge Fund 6.512 2392412 348698 2023-06-30 MED
    Segall Bryant & Hamill, LLC Investment Advisor/Hedge Fund 5.6224 2065583 -20143 2023-06-30 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 4.3034 1581014 15098 2023-06-30 LOW
    Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 3.2086 1178787 28746 2023-06-30 LOW
    Emerald Advisers LLC Investment Advisor 2.7763 1019963 -250016 2023-09-30 MED
    Paradice Investment Management LLC Investment Advisor 2.5613 940975 -11792 2023-06-30 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.9255 707418 26255 2023-06-30 LOW
    Renaissance Technologies LLC Hedge Fund 1.6003 587921 -95499 2023-06-30 HIGH
    ExodusPoint Capital Management, LP Hedge Fund 1.2185 447668 317079 2023-06-30 HIGH
    Charles Schwab Investment Management, Inc. Investment Advisor 1.1131 408950 17879 2023-06-30 LOW
    Columbia Threadneedle Investments (US) Investment Advisor/Hedge Fund 0.9826 361009 -66463 2023-06-30 LOW
    AWM Investment Company, Inc. Investment Advisor/Hedge Fund 0.9183 337382 -121441 2023-06-30 LOW
    Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.8978 329839 5865 2023-06-30 LOW
    Parametric Portfolio Associates LLC Investment Advisor 0.8276 304052 28265 2023-06-30 LOW
    First Eagle Investment Management, L.L.C. Investment Advisor/Hedge Fund 0.6822 250620 174655 2023-06-30 LOW
    Great Lakes Advisors, LLC Investment Advisor 0.6782 249165 72383 2023-06-30 MED

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Orthofix Company profile

    About Orthofix Medical Inc

    Orthofix Medical Inc. is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The Company has two reporting segments: Global Spine and Global Orthopedics. The Global spine segment provide three product categories such as Bone Growth Therapies, Spinal Implants, and Biologics. Its products also consist of bone growth therapies devices, motion preservation products, spine fixation products, and orthopedics products. The Global Orthopedics offers products and solutions that allow physicians to treat a variety of orthopedic conditions in adults and children unrelated to the spine. It distribute its products globally to hospitals and health providers.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Orthofix Medical Inc revenues increased 14% to $464.5M. Net loss totaled $38.4M vs. income of $2.5M. Revenues reflect Global Spine segment increase of 12% to $359M, United States segment increase of 11% to $361.9M, United Kingdom segment increase of 48% to $10.6M. Net loss reflects Sales and marketing - Balancing value increase of 9% to $217.9M (expense), Other income (expense).

    Equity composition

    Common Stock $.10 Par, 07/10, 50M auth., 17,641,438 issd. Insiders own 1.39%. IPO 4/92, 3M shares @ $12 by Alex.Brown.

    Industry: Medical Equipment, Supplies & Distribution (NEC)

    3451 Plano Pkwy
    LEWISVILLE
    TEXAS 75056-9453
    US

    Income Statement

    • Annual
    • Quarterly

    News

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023
    GBP

    UK AUTUMN BUDGET: Will Hunt cut taxes? How will GBP react this time around?

    UK Chancellor Hunt will deliver the 2023 autumn statement to MPs on Wednesday 22 November.

    10:48, 21 November 2023

    People also watch

    Gold

    2,049.50 Price
    +0.460% 1D Chg, %
    Long position overnight fee -0.0196%
    Short position overnight fee 0.0114%
    Overnight fee time 22:00 (UTC)
    Spread 0.50

    XRP/USD

    0.61 Price
    -0.110% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    BTC/USD

    38,429.45 Price
    +1.690% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Oil - Crude

    76.22 Price
    +1.340% 1D Chg, %
    Long position overnight fee -0.0165%
    Short position overnight fee -0.0054%
    Overnight fee time 22:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading